Churg–Strauss syndrome: evidence for disease subtypes?
- 1 January 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Rheumatology
- Vol. 22 (1), 21-28
- https://doi.org/10.1097/bor.0b013e328333390b
Abstract
Churg-Strauss syndrome (CSS) is a rare systemic small-vessel necrotizing vasculitis. Its main clinical characteristics, some potentially life-threatening, are now well known, as are its usual successive phases, from allergic rhinitis to asthma, and finally vasculitis. Conversely, physiopathogenetic mechanisms are not completely elucidated and clearly multiple, thereby suggesting the existence of different disease subtypes.Almost 40% of CSS patients have circulating antineutrophil cytoplasm autoantibodies (ANCAs), mostly directed against myeloperoxidase. ANCA-positive patients suffer more frequently from renal disease, peripheral nervous system involvement and/or alveolar hemorrhage, whereas frequent cardiac involvement, lung infiltrates and/or systemic manifestations are more common in those who are ANCA-negative. However, their respective global outcomes do not clearly differ. Patients might also be categorized according to other, more subtle clinical, radiological and/or biological parameters, for example, cardiac magnetic resonance imaging abnormalities or genetic background.Because of its practical and therapeutic repercussions, the priority remains the prompt, relatively easy identification of the most severely affected patients at CSS diagnosis, before searching for and trying to classify subsets. Large, collaborative studies are needed to determine whether other subgroups might be associated with outcomes and warrant different, and possibly new, therapeutic strategies.Keywords
This publication has 102 references indexed in Scilit:
- Cardiac Involvement in Churg-Strauss SyndromeMedicine, 2009
- Establishment of Experimental Eosinophilic Vasculitis by IgE-Mediated Cutaneous Reverse Passive Arthus ReactionThe American Journal of Pathology, 2009
- First-pass myocardial perfusion abnormalities in Churg-Strauss Syndrome with cardiac involvementThe International Journal of Cardiovascular Imaging, 2009
- FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophiliaBMC Hematology, 2009
- Hypereosinophilic syndromesOrphanet Journal of Rare Diseases, 2007
- Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseasesEuropean Journal of Pharmacology, 2006
- Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndromeAnnals Of The Rheumatic Diseases, 2006
- New genomic region for Wegener?s granulomatosis as revealed by an extended association screen with 202 apoptosis-related genesHuman Genetics, 2004
- Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulinAnnals of Allergy, Asthma & Immunology, 2004
- IgE‐Containing Circulating Immune Complexes in Churg‐Strauss VasculitisScandinavian Journal of Immunology, 1985